News Center



Home News Center Events

MBA Lectern: Digital Healthcare and Digital Transformation of Pharmaceutical Firms in AI LLM Era

Jun 09-2024   



Event Information

Time: 18:30-20:00, June 9 (Sunday), 2024

Venue: 131 Classroom, NSD at PKU

Agenda:

18:30-18:40 Opening introduction

18:40-19:40 Thematic Sharing: Digital Healthcare and Digital Transformation of Pharmaceutical Firms in AI Large-Language-Model Era

Key points:

1. New digital paradigms and fresh development opportunities for firms

2. New opportunities in digital healthcare in AI LLM era

3. Digital transformation of pharmaceutical firms and value chain innovation of traditional Chinese medicine

19:40-20:00 Q&A and exchange of ideas

 

About Speaker

Mr. Li Shaochun is Digital Strategy Scientist of Yunnan Baiyao, a leading pharmaceutical firm specializing in traditional Chinese medicine, and General Manager and CIO of its Smart Tech Business Unit. Mr. Li focuses on the deep integration of professional scenarios in healthcare and cutting-edge digital technologies and has ample practical experiences in Big Health. He has been unwaveringly dedicated to frontier research and innovation in big data analysis, artificial intelligence, cloud computing, and internet of things, promoting the strategy and implementation of global innovation collaboration, driving solutions for AI technology and ecosystem innovation, assisting the digitalized reshaping of complete value chains of companies in healthcare and life science, and providing them with the indispensable insight for making crucial decisions concerning healthcare, clinical diagnosis, operation, and innovation. As such, companies and organizations can use leading technologies to achieve credible transformation into digital, smart platforms.

 

Mr. Li is committed to forging a smart healthcare innovation ecosystem. He maintains close ties and cooperation with clinicians, researchers, data scientists, government agencies, thought leaders, and Big Health companies, and is devoted to digital, smart reinvention by amalgamating data, technology, and business. As an industry leader, Mr. Li is a sought-after speaker at major global and domestic tech conventions on AI, pharmaceutical R&D, healthcare, and relevant industries. He pursued studies at Cheung Kong Graduate School of Business and Guanghua School of Management, Peking University. He is on the specialist boards of College of Engineering, Peking University, and a leading pharmaceutical magazine.

 

Mr. Li’s previous positions included General Manager of IBM Greater China Healthcare and Life Science, General Manager of IBM Greater China Watson Health, and Director of Research Technology Innovation of IBM Research-China. As IBM Master Inventor (with over 60 patents), he won 15 annual tech achievement awards of IBM global research, of which three were for outstanding accomplishments. He was presented with many global awards by IBM for outstanding performances in business, technology, and management.

 

MBA Lectern: Digital Healthcare and Digital Transformation of Pharmaceutical Firms in AI LLM Era

Jun 09-2024   



Event Information

Time: 18:30-20:00, June 9 (Sunday), 2024

Venue: 131 Classroom, NSD at PKU

Agenda:

18:30-18:40 Opening introduction

18:40-19:40 Thematic Sharing: Digital Healthcare and Digital Transformation of Pharmaceutical Firms in AI Large-Language-Model Era

Key points:

1. New digital paradigms and fresh development opportunities for firms

2. New opportunities in digital healthcare in AI LLM era

3. Digital transformation of pharmaceutical firms and value chain innovation of traditional Chinese medicine

19:40-20:00 Q&A and exchange of ideas

 

About Speaker

Mr. Li Shaochun is Digital Strategy Scientist of Yunnan Baiyao, a leading pharmaceutical firm specializing in traditional Chinese medicine, and General Manager and CIO of its Smart Tech Business Unit. Mr. Li focuses on the deep integration of professional scenarios in healthcare and cutting-edge digital technologies and has ample practical experiences in Big Health. He has been unwaveringly dedicated to frontier research and innovation in big data analysis, artificial intelligence, cloud computing, and internet of things, promoting the strategy and implementation of global innovation collaboration, driving solutions for AI technology and ecosystem innovation, assisting the digitalized reshaping of complete value chains of companies in healthcare and life science, and providing them with the indispensable insight for making crucial decisions concerning healthcare, clinical diagnosis, operation, and innovation. As such, companies and organizations can use leading technologies to achieve credible transformation into digital, smart platforms.

 

Mr. Li is committed to forging a smart healthcare innovation ecosystem. He maintains close ties and cooperation with clinicians, researchers, data scientists, government agencies, thought leaders, and Big Health companies, and is devoted to digital, smart reinvention by amalgamating data, technology, and business. As an industry leader, Mr. Li is a sought-after speaker at major global and domestic tech conventions on AI, pharmaceutical R&D, healthcare, and relevant industries. He pursued studies at Cheung Kong Graduate School of Business and Guanghua School of Management, Peking University. He is on the specialist boards of College of Engineering, Peking University, and a leading pharmaceutical magazine.

 

Mr. Li’s previous positions included General Manager of IBM Greater China Healthcare and Life Science, General Manager of IBM Greater China Watson Health, and Director of Research Technology Innovation of IBM Research-China. As IBM Master Inventor (with over 60 patents), he won 15 annual tech achievement awards of IBM global research, of which three were for outstanding accomplishments. He was presented with many global awards by IBM for outstanding performances in business, technology, and management.